Shanghai, June 20, 2024 – BioDuro-Sundia, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO) and an Advent International portfolio company, announced that it has been named "Premium Global Partner" at CPHI China Pharma Awards 2024. This award is given to products or services that are highly recognized in the global market.
BioDuro-Sundia is delighted to receive the "Premium Global Partner" award, which is the industry's recognition of our comprehensive strength and innovation capability. We will always support the global pharmaceutical and biotech companies to discover and develop new drugs in a science-driven way with our continued high quality and efficient services.
BioDuro-Sundia provides fully integrated services from target identification to commercial drug product manufacturing. Core expertise includes small and large molecule discovery, development and scale up, support for IND submission, and unique technology platforms. Headquartered in Irvine, California, our global presence spans 7 sites across 6 cities, providing innovative drug research and development services to more than 1,500 customers around the world.
About Premium Global Partner
CPHI China Pharma Awards adheres to the industrial thinking, based on the global vision, with professional evaluation criteria and industry voting, to recognize the innovation benchmarks and empower the high-quality development of the pharmaceutical industry. The "Premium Global Partner" is given to products or services recognized in the global market. Through online voting, the Chinese companies that overseas pharmaceutical companies would like to cooperate with and the international suppliers that are well recognized by domestic companies will be selected.
About BioDuro-Sundia
BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research, development, and manufacturing organization (CRDMO) with over 28 years of expertise. Global headquarter in Irvine, California, our global presence spans 7 sites across 6 cities, totaling 2,000+ employees. Specializing in small and large molecule discovery, development, scale-up and manufacturing, we offer fully integrated services from target identification to commercial drug product manufacturing. At BioDuro-Sundia, we leverage our unique technology platforms to support biotech and pharmaceutical partners worldwide. Our comprehensive approach accelerates discovery, de-risks development, and creates higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, diversified and people-focused culture. Dedicated to CRDMO Service business, BioDuro-Sundia operates under one global standard, providing top-tier, integrated, fast, and flexible tailored services to meet the unique needs of our clients and accelerate development timelines. For more information, please visit https://www.bioduro-sundia.com
Home
